Tradestie Institutional Equity Comparison Engine

RBOT.WS vs ESTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ESTA Overall Edge

ESTA Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Establishment Labs Holdings Inc. (ESTA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ESTA at N/M Forward P/E and -6.6% operating margin (+33.9% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ESTA sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RBOT.WS N/M vs ESTA N/M Fwd P/E
Growth & Margin Winner ESTA
Op Margin N/A vs -6.6% ยท YoY N/A vs +33.9%
Momentum & Technical Winner ESTA
1Y -67.2% vs +3.4% ยท 52W Pos 0% vs 36%
Options & Structure Winner ESTA
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (5th %ile IV)
RBOT.WS NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap N/A
1M Return -67.2%
1Y Return -67.2%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
ESTA NASDAQ
Establishment Labs Holdings Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$69.14
-0.68% 1D
Market Cap $2.1B
1M Return +8.85%
1Y Return +3.44%
Forward P/E N/M
Unified AI Score
35.7 / 100 SELL
Tech 35.0 Fund 40.0 Flow 61.0 Mom 21.4

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RBOT.WS -67.2% ESTA +3.44% Spread: +76.84 pp (ESTA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RBOT.WS TTM Op. Margin: N/A ESTA TTM Op. Margin: -6.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs ESTA. Trailing 12-month operating profitability (RBOT.WS N/A vs ESTA -6.6%) and valuation multiples (RBOT.WS N/M vs ESTA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RBOT.WS (1) vs ESTA (7)
Institutional Metric RBOT.WS ESTA Criterion Row Winner
Market Capitalization Scale N/A $2.1B Larger Scale ESTA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +33.9% Higher Growth ESTA
Operating Margin (TTM) Profitability N/A -6.6% Higher Margin ESTA
Net Profit Margin Profitability N/A -14.6% Higher Margin ESTA
Return on Equity (ROE) Capital Efficiency N/A -240.7% Higher ROE ESTA
52-Week Range Position Momentum 0% ($0โ€“$0) 36% ($53โ€“$98) Stronger Trend ESTA
Beta / 30D Volatility Risk Regime N/A 1.49ฮฒ ยท 57% Vol Lower Realized Risk ESTA
Unified Institutional Score Composite Signal 50.1 / 100 (HOLD) 35.7 / 100 (SELL) Higher Composite RBOT.WS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RBOT.WS vs ESTA Buy Guide
RBOT.WS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RBOT.WS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ESTA CONSOLIDATION
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live ESTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RBOT.WS nor ESTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.